<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Molecular Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E192254A-182A-41E7-A6A9-E0892127BD83"><gtr:id>E192254A-182A-41E7-A6A9-E0892127BD83</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Knight</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E56CAE96-E8B2-4100-90AC-727DC450A92D"><gtr:id>E56CAE96-E8B2-4100-90AC-727DC450A92D</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Wilson</gtr:otherNames><gtr:surname>Ironside</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9"><gtr:id>23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600953"><gtr:id>2D264B93-1631-4203-8CF9-EB722A40B7FE</gtr:id><gtr:title>The NCJDSU Tissue Resource: support for continued banking activities</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600953</gtr:grantReference><gtr:abstractText>Prion diseases are fatal disorders that affect the brain, and include diseases such as BSE or ?mad cow disease? in cattle and CJD in humans. One form of CJD, known as variant CJD, is linked to exposure to BSE through the diet. Prion diseases are transmissible, and studies of CJD and BSE have shown that the infectious agent accumulates at highest levels in the brain. However, the agent can also be present in a range of other tissues throughout the body. The aim of this research is to continue the collection and storage of tissues from all forms of CJD in a bank in the National CJD Surveillance Unit, Edinburgh. This bank played a key role in the discovery of variant CJD, and is used by a wide range of researchers in UK and across the world. The material collected comes from tissue and organs taken at autopsy from patients with suspected CJD only when the relatives have given consent. We also collect blood samples from living patients, again with the consent of the relatives. The bank has approval for this work from our local Ethical Committee, and has been used for many research projects, resulting in major scientific and medical publications. The information from this research has also made a big impact on the work of the NHS, particularly in steps to reduce the chance of transmission of variant CJD by blood transfusion and by surgical instruments. We believe that the bank will continue to be needed by researchers in the UK and elsewhere in the future, since there are so many unanswered questions about this group of diseases. There is also a major need to help develop a test for CJD that can be used on living patients, which will be helped by the use of the tissue and blood samples in our bank. We run the bank according to MRC guidelines, and plan to use a MRC Steering Group (which includes 2 members of the public) to oversee our work. The results from our work are presented in many forms, such as scientific and medical papers, lectures (including public lectures) and in interviews with the press, radio and television.</gtr:abstractText><gtr:technicalSummary>This application seeks to renew MRC support for the National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU) tissue resource, to help fill research needs in human prion diseases in the UK and overseas. Creutzfeldt-Jakob disease (CJD) is one of a group of fatal transmissible neurodegenerative disorders known as prion diseases. These disorders have reached enormous significance in UK since the epidemic of bovine spongiform encephalopathy (BSE) and the subsequent emergence of variant CJD (vCJD), which results from BSE infection in humans. The identification and characterisation of vCJD was critically dependent on the availability of a wide range of tissues, blood, cerebrospinal fluid and DNA and in a variety of forms (fixed, frozen etc) from the tissue resource in the NCJDSU. This resource is recognised as a unique collection and has been used by all the leading research groups in the field on a worldwide basis. The continuing uncertainties over the incidence of vCJD infection in the UK population, the tissue distribution of infectivity in all forms of human prion disease, the need to study the strains of the infectious agent in human prion disease and to understand the mechanisms of disease pathogenesis all reinforce the requirement for well characterised tissues that are available in a range of forms to maximise potential research use. The demands for materials in the NCJDSU tissue resource are not confined to vCJD, and encompass all forms of human prion disease (except kuru). The support requested is modest and comprises one technical post, support for a new freezer and a small amount of consumables. The infrastructure of NCJDSU allows a range of backup facilities (computer support, staff cover) that allow this to be a cost-effective application. The NCJDSU tissue resource has LREC approval to store and use autopsy tissues for research purposes, and operates to MRC guidance for brain banks, with strategic oversight and advice on resource allocation from the Tissue Management Group in the Department of Health. We propose that the NCJDSU tissue resource should come under the MRC Steering Group for the Edinburgh Brain Banks for HIV and Sudden Death for matters of research governance. Data arising from research performed on the NCJDSU resource has generated a large quantity of publications in leading scientific and medical journals, and has provided considerable input to policy formulation and risk assessment in the UK and overseas. These important activities will be not only maintained, but strengthened by this application.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>238893</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>7017C034-A077-4D70-83BF-43E07E45AACF</gtr:id><gtr:impact>Public lecture - 400 attendees, including schoolchildren and students

Extensive media coverage</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>169456</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>12ABF796-889C-4F85-ACAA-E2F6C69423DB</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Infectivity in vCJD tissues</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2EB36D85-6654-450D-893D-3998FDFD0D14</gtr:id><gtr:impact>Health and Saefty Guidlines for those working with TSE tissues in laboratories or patients in a clinical setting</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Sporadic and variant CJD brain tissue samples</gtr:description><gtr:id>E95CB828-43E6-4B1D-91B8-8F3AE6E2AD85</gtr:id><gtr:impact>Publications, many of which are listed in the publications section of this return</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reference materials supplies to WHO and to NIBSC</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F8ECB9CD-9343-4D4B-9E94-0FB8BB9E8675"><gtr:id>F8ECB9CD-9343-4D4B-9E94-0FB8BB9E8675</gtr:id><gtr:title>Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4bb1df96eb6c522533fcf07eeb565f27"><gtr:id>4bb1df96eb6c522533fcf07eeb565f27</gtr:id><gtr:otherNames>Fairfoul G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2EDC4E16-45A2-44B5-B4E9-AD980D8FE4B5"><gtr:id>2EDC4E16-45A2-44B5-B4E9-AD980D8FE4B5</gtr:id><gtr:title>Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/beb95ebb21fcd54384b2e59882c8d9ea"><gtr:id>beb95ebb21fcd54384b2e59882c8d9ea</gtr:id><gtr:otherNames>Concha-Marambio L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3496328-F43C-48F0-9B3F-41107A89A47B"><gtr:id>B3496328-F43C-48F0-9B3F-41107A89A47B</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB3EBA98-DB18-400D-9BED-F23140AF6251"><gtr:id>DB3EBA98-DB18-400D-9BED-F23140AF6251</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/641C86CB-83F3-434A-BEA7-C3340C0B3D1C"><gtr:id>641C86CB-83F3-434A-BEA7-C3340C0B3D1C</gtr:id><gtr:title>Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; experimental ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb7426edb632ee5399bf187b2d76a4d2"><gtr:id>eb7426edb632ee5399bf187b2d76a4d2</gtr:id><gtr:otherNames>Tullo AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1442-6404</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2913F92-0F0E-4F32-BBF6-BBA37540D194"><gtr:id>A2913F92-0F0E-4F32-BBF6-BBA37540D194</gtr:id><gtr:title>Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/acf0ecdbbd10a5abf267a3eae39d2b5b"><gtr:id>acf0ecdbbd10a5abf267a3eae39d2b5b</gtr:id><gtr:otherNames>Yull HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9A5E2C8-D1AE-48E6-BA85-5102BF7CAF05"><gtr:id>E9A5E2C8-D1AE-48E6-BA85-5102BF7CAF05</gtr:id><gtr:title>UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C064C89-9748-4A4D-A81C-9C1AD5FE8A6A"><gtr:id>5C064C89-9748-4A4D-A81C-9C1AD5FE8A6A</gtr:id><gtr:title>Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1cdc869fdb7df38fa1e256edb618b6f"><gtr:id>c1cdc869fdb7df38fa1e256edb618b6f</gtr:id><gtr:otherNames>Parchi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D3837CF-6969-44A0-8157-949249D16879"><gtr:id>5D3837CF-6969-44A0-8157-949249D16879</gtr:id><gtr:title>Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Transfusion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0041-1132</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F2E9C12-29CB-45F7-BC1D-DD3627848C3E"><gtr:id>8F2E9C12-29CB-45F7-BC1D-DD3627848C3E</gtr:id><gtr:title>Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin.</gtr:title><gtr:parentPublicationTitle>Transfusion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc4c58d9e84539274a9200be96bf52cd"><gtr:id>dc4c58d9e84539274a9200be96bf52cd</gtr:id><gtr:otherNames>Oshita M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0041-1132</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D2D2647-CDF0-4437-BEB8-AEC6999D1D06"><gtr:id>1D2D2647-CDF0-4437-BEB8-AEC6999D1D06</gtr:id><gtr:title>Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d01be4e5ebcfec24b2e66bf35579f82"><gtr:id>4d01be4e5ebcfec24b2e66bf35579f82</gtr:id><gtr:otherNames>Uro-Coste E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F328A4A-F1B8-4D7D-BB1C-747F8F6E5387"><gtr:id>7F328A4A-F1B8-4D7D-BB1C-747F8F6E5387</gtr:id><gtr:title>Predicting susceptibility and incubation time of human-to-human transmission of vCJD.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C00E59F-4745-4DAF-B0C5-D65496C82F2F"><gtr:id>9C00E59F-4745-4DAF-B0C5-D65496C82F2F</gtr:id><gtr:title>Dementia with Lewy bodies associated with ataxia, myoclonus, and cortical blindness.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90e65cba6627e4797ac896340a44b100"><gtr:id>90e65cba6627e4797ac896340a44b100</gtr:id><gtr:otherNames>Hindle JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B994159-411C-4125-929F-7E3C42F9C8D9"><gtr:id>9B994159-411C-4125-929F-7E3C42F9C8D9</gtr:id><gtr:title>No major change in vCJD agent strain after secondary transmission via blood transfusion.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57216769-F176-410F-A042-C9B5E59EA3C9"><gtr:id>57216769-F176-410F-A042-C9B5E59EA3C9</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36A67865-BF1E-4CC6-BEC7-34B250F30D5F"><gtr:id>36A67865-BF1E-4CC6-BEC7-34B250F30D5F</gtr:id><gtr:title>The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/883AF744-AFE3-468B-862B-4316A3902A88"><gtr:id>883AF744-AFE3-468B-862B-4316A3902A88</gtr:id><gtr:title>Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/60dc254158d22ff0ccd17fa994121d19"><gtr:id>60dc254158d22ff0ccd17fa994121d19</gtr:id><gtr:otherNames>Clewley JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71355E3B-BB76-4893-80AB-272FF854D906"><gtr:id>71355E3B-BB76-4893-80AB-272FF854D906</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/358250A9-A42A-4273-BB2A-968803411B28"><gtr:id>358250A9-A42A-4273-BB2A-968803411B28</gtr:id><gtr:title>Clusterin expression in follicular dendritic cells associated with prion protein accumulation.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dcb9a592a95f7031a08f7d4cab6a3b97"><gtr:id>dcb9a592a95f7031a08f7d4cab6a3b97</gtr:id><gtr:otherNames>Sasaki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83D18485-15C6-4B29-B768-FEB137B5D981"><gtr:id>83D18485-15C6-4B29-B768-FEB137B5D981</gtr:id><gtr:title>Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dac2d08588f2437846bb06495fe403c0"><gtr:id>dac2d08588f2437846bb06495fe403c0</gtr:id><gtr:otherNames>Heath CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AFAEDB5-1A9D-48EE-8E4C-8A702A6CF1C4"><gtr:id>1AFAEDB5-1A9D-48EE-8E4C-8A702A6CF1C4</gtr:id><gtr:title>Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25671A76-4AC2-43E4-BFFB-485EC52DA5E1"><gtr:id>25671A76-4AC2-43E4-BFFB-485EC52DA5E1</gtr:id><gtr:title>Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Str&amp;auml;ussler-Scheinker disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3cd41808812882abfbd34ec82d751c75"><gtr:id>3cd41808812882abfbd34ec82d751c75</gtr:id><gtr:otherNames>Sikorska B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94674155-C665-4AD0-B508-EE269BAD5488"><gtr:id>94674155-C665-4AD0-B508-EE269BAD5488</gtr:id><gtr:title>Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e90a2f64b84a8ace7f0bd4aa1ac943f5"><gtr:id>e90a2f64b84a8ace7f0bd4aa1ac943f5</gtr:id><gtr:otherNames>Goodall CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BAA2412-179A-44F9-8E89-DA4CFDB7424A"><gtr:id>7BAA2412-179A-44F9-8E89-DA4CFDB7424A</gtr:id><gtr:title>Biology and neuropathology of prion diseases.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4030961D-DEB5-4744-80B9-D6C59FC3DFC1"><gtr:id>4030961D-DEB5-4744-80B9-D6C59FC3DFC1</gtr:id><gtr:title>Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f40fc0363daa5a951e8f3d157f455f35"><gtr:id>f40fc0363daa5a951e8f3d157f455f35</gtr:id><gtr:otherNames>Cescatti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AC2CF56-81C8-48B4-8D98-8D187A3CAEC7"><gtr:id>2AC2CF56-81C8-48B4-8D98-8D187A3CAEC7</gtr:id><gtr:title>Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03e8b39a903bf2641c971a207456f49d"><gtr:id>03e8b39a903bf2641c971a207456f49d</gtr:id><gtr:otherNames>Lourenco PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B7F5372-1A73-42B0-850A-8B3FB4E646C7"><gtr:id>8B7F5372-1A73-42B0-850A-8B3FB4E646C7</gtr:id><gtr:title>Size frequency distributions of the florid prion protein aggregates in variant Creutzfeldt-Jakob disease follow a power-law function.</gtr:title><gtr:parentPublicationTitle>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c51118a9b283eac54a22a4a597e497d3"><gtr:id>c51118a9b283eac54a22a4a597e497d3</gtr:id><gtr:otherNames>Armstrong RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1590-1874</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF3CDC55-0DF9-4A5E-8E0C-C40A206B1ADE"><gtr:id>CF3CDC55-0DF9-4A5E-8E0C-C40A206B1ADE</gtr:id><gtr:title>Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a439e3cead6e102b8a7c8e439170b4fb"><gtr:id>a439e3cead6e102b8a7c8e439170b4fb</gtr:id><gtr:otherNames>Wei W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BFA5E1B-F5F1-4283-AC03-FEB40037D5F0"><gtr:id>2BFA5E1B-F5F1-4283-AC03-FEB40037D5F0</gtr:id><gtr:title>Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/428563A1-DEC2-46DA-A032-1D603A2A1F72"><gtr:id>428563A1-DEC2-46DA-A032-1D603A2A1F72</gtr:id><gtr:title>An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22D48F6D-A1A8-4141-8D62-17E3ED36EF07"><gtr:id>22D48F6D-A1A8-4141-8D62-17E3ED36EF07</gtr:id><gtr:title>vCJD prion acquires altered virulence through trans-species infection.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8085e58ad0688084bd88795edbb9e8d"><gtr:id>f8085e58ad0688084bd88795edbb9e8d</gtr:id><gtr:otherNames>Asano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BEC2F0F7-81E8-4463-A9C7-5E7D323AC69B"><gtr:id>BEC2F0F7-81E8-4463-A9C7-5E7D323AC69B</gtr:id><gtr:title>Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFC1D59C-2107-44C1-B202-CB96089E1372"><gtr:id>AFC1D59C-2107-44C1-B202-CB96089E1372</gtr:id><gtr:title>Sporadic and Infectious Human Prion Diseases.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5cc148a1af756621f53e2c335b8d343"><gtr:id>c5cc148a1af756621f53e2c335b8d343</gtr:id><gtr:otherNames>Will RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E19FCD03-1538-4FB1-8CD3-44D7BAECB894"><gtr:id>E19FCD03-1538-4FB1-8CD3-44D7BAECB894</gtr:id><gtr:title>Relative Abundance of apoE and A?1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600953</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>